Powder

FDA-Approved Afrezza: An Inhaled Alternative to Injectable Insulin?

By: Elissa Tam, PharmD Candidate c/o 2015 - Patients with Type 1 or Type 2 diabetes who cannot control their…

12 years ago

The Use of Topical Opioid Treatment for Pressure Ulcer Wounds

By: Katharine Cimmino, Editor-in-Chief - Pressure ulcers can be a painful condition decreasing the quality of life of patients and…

12 years ago

New Alternative First Line Therapy for EGFR NSCLC

By: Jenny Park, PharmD Candidate c/o 2015 - On July 12, 2013, the FDA approved afatinib (GilotrifTM) as a new…

12 years ago

Possible Inhaled Option for Diabetics

By: Sang Hyo Kim, Staff Editor - Near the end of December, the pharmaceutical company, MannKind Corp, will submit their…

13 years ago

VarizigĀ® for Chickenpox Symptoms

By: Steve Soman, Co-Editor-in-Chief - Varicella Zoster Immune Globulin (VarizigĀ®) was approved by the FDA on December 21st of 2012.…

13 years ago

Artificial Saliva Agents in Xerostomia

By: Neal Shah, Co-Editor-in-Chief - Xerostomia, commonly known as dry mouth, is an anti-muscarinic side effect of numerous medications. Ā Antidepressants,…

14 years ago

Counterfeit Prescription Medications: A Global Threat

By: Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 - Counterfeit prescription medications are becoming a great concern for us. They…

14 years ago

My Residency, My Experience, A Foundation for My Career

By: Sum Lam, PharmD, CGP, BCPS, FASCP - Sum Lam, Pharm.D., CGP, BCPS, FASCP is an Associate Clinical Professor in…

14 years ago